Navigation Links
KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification
Date:10/15/2009

ncer and in more than 80 countries for the treatment of patients with advanced kidney cancer. In Europe, Nexavar is approved for the treatment of hepatocellular carcinoma and for the treatment of patients with advanced renal cell carcinoma (RCC) who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy. Nexavar targets both the tumor cell and tumor vasculature. In preclinical studies, Nexavar has been shown to target members of several classes of kinases known to be involved in both cell proliferation (growth) and angiogenesis (blood supply) two important processes that enable cancer growth. These kinases included Raf, VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-B, KIT, FLT-3 and RET. Nexavar is currently being evaluated as a single agent or combination treatment in a wide range of cancers, including lung, ovarian and colorectal cancer and as an adjuvant therapy for liver and kidney cancer.

About Onyx Pharmaceuticals, Inc. - www.onyx-pharm.com
Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar (Sorafenib) tablets, a small molecule drug.

About Bayer Schering Pharma - www.bayerscheringpharma.de
Bayer Schering Pharma is a worldwide leading specialty pharmaceutical company. Its research and business activities are focused on the following areas: Diagnostic Imaging, General Medicine, Specialty Medicine and Women's Healthcare. With innovative products, Bayer Schering Pharma aims for leading positions in specialized markets worldwide. Using new ideas, Bayer Schering Pharma aims to make a contribution to medical progress and strives to improve the quality of life.


C
'/>"/>

b3c newswire

Page: 1 2 3 4

Related biology news :

1. KINAXOs Cellular Target Profiling reveals mTOR as a new target of Celebrex
2. KINAXO launches KinAffinity services for efficient profiling of kinase inhibitors in cells or tissue
3. VIB and Bayer join forces for plant research
4. Ben-Gurion University of the Negev signs collaborative contract with Bayer CropScience
5. ERS-2 data vital for maritime security
6. New discovery on role of vital protein that fights meningitis
7. Gap junction protein vital to successful pregnancy, researchers find
8. Herbicide-resistant grape could revitalize Midwest wine industry
9. Loggerhead release to provide vital information to scientific community
10. Researchers first to see reactive oxygen species in vital enzyme
11. Understanding phosphorus in soils is vital to proper management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... study of identical twins has found that early reading ... in the journal Child Development , was conducted ... College London. , "Since reading is an ability that ... instruction," according to Stuart J. Ritchie, research fellow in ... study. "Early remediation of reading problems might aid not ...
(Date:7/23/2014)... North Carolina State University shows that urban "heat islands" ... States. One factor is that researchers have found warmer ... gloomy scale insect a significant tree pest ... times more adult gloomy scales on urban trees. , ... the gloomy scale in cities, and now we know ...
(Date:7/23/2014)... tissue samples cultured from cystic fibrosis patients, scientists at ... Lung Institute have shown that a new CF drug ... drug. , The finding, published today in the journal ... CFTR protein becomes unstable and loses its ability to ... drugs. The research offers several insights into how novel ...
Breaking Biology News(10 mins):Stronger early reading skills predict higher intelligence later 2Urban heat boosts some pest populations 200-fold, killing red maples 2Urban heat boosts some pest populations 200-fold, killing red maples 3UNC researchers find unsuspected characteristics of new CF drugs, offering potential paths to more effective therapies 2UNC researchers find unsuspected characteristics of new CF drugs, offering potential paths to more effective therapies 3UNC researchers find unsuspected characteristics of new CF drugs, offering potential paths to more effective therapies 4
... 25, 2012Warner C. Greene, MD, PhDwho directs virology ... the 2012 Alumni Achievement Award from the Washington ... This prestigious award acknowledges outstanding personal achievement ... the Washington University Medical Center. Dr. Greene trained ...
... MEDIA ALERT , "Basic science and clinical medicine ... however aim at improving strategies to manage cancer patients. We ... and efficiently implement them in the clinic." Sherene ... 2012 will focus on four major areas: , ...
... Barbara, Calif.) An international team of researchers has ... happens in virtually every cell of our bodies. ... chains of amino acids assume their specific shapes, hence ... In the human body, proteins fold to become muscles, ...
Cached Biology News:Gladstone scientist Warner C. Greene receives Washington University School of Medicine Alumni Award 2Fourth IMPAKT Breast Cancer Conference 2Fourth IMPAKT Breast Cancer Conference 3In protein folding, internal friction may play a more significant role than previously thought 2
(Date:7/23/2014)... 2014  Sofinnova Ventures, a Menlo Park ... of Sofinnova Venture Partners IX, L.P. at the hard ... initial fund target of $425 million. Sofinnova ... Consistent with recent funds, SVP IX will provide capital ... along with select investments in earlier stage opportunities. Investments ...
(Date:7/23/2014)... MA (PRWEB) July 23, 2014 ... medicine transplant therapies are biological, but not magical. ... may seem to treat them as if they ... well as unsanctioned studies that constitute “stem cell ... as an approach to developing new regenerative medicine ...
(Date:7/22/2014)... Researchers from the National Institute of Standards and ... have demonstrated a new design for an atomic ... comb, or a microcomb. , The microcomb clock, ... of the new journal Optica ,* is ... microcomb, and its accurate conversion of optical frequencies ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 CTD Holdings, ... the pharmaceutical, medical device, cosmetics, and other markets, announced ... with a group of qualified private investors led by ... , The transaction involved the signing of ... 1,725,000 shares of Common Stock at a price per ...
Breaking Biology Technology:Sofinnova Raises $500 Million Biotech Venture Fund 2The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 2The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 3The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 4The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 5'Comb on a chip' powers new NIST/Caltech atomic clock design 2CTD Holdings Closes $1.725 Million Private Placement 2CTD Holdings Closes $1.725 Million Private Placement 3
... Madison University of Wisconsin-Madison researcher Scott Sanders has ... one but a rainbow of colors, and to deliver the ... for scanning objects. , ,Researchers can derive information about a ... system allows them to try a full range of colors ...
... approaching and you're really feeling like a salary increase should ... have a great argument for your boss to get him ... dollars are tight and your boss is pre-disposed (or programmed ... ignore or discount most pay-me-more arguments. , ,So how can ...
... a new biomedical institute on Monday in Milwaukee. ... researchers and companies in southeastern Wisconsin is the goal ... is being established with a $1 million grant from ... Institute for Biomedical and Health Technologies is intended to ...
Cached Biology Technology:Want a raise? Ten best midwest tech salary-increase pitches 2Want a raise? Ten best midwest tech salary-increase pitches 3Want a raise? Ten best midwest tech salary-increase pitches 4Want a raise? Ten best midwest tech salary-increase pitches 5New biomedical institute aims to unite business and academia in SE Wisconsin 2New biomedical institute aims to unite business and academia in SE Wisconsin 3New biomedical institute aims to unite business and academia in SE Wisconsin 4